Stocktoria
GRAIL, Inc. GRAL
Nasdaq · XNAS · stock · Services-Medical Laboratories · website · IPO 2024-06-12
Chart by TradingView
4/9
Piotroski F — financial health
-2.86
Altman Z″ — distress risk · distress
—
Dividend payout · no dividend
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Financials | |||
| Revenue | $147.2M | $125.6M | $93.1M |
| Operating income | -$562.2M | -$2.2B | -$1.5B |
| Net income | -$408.4M | -$2.0B | -$1.5B |
| Operating cash flow | -$299.0M | -$577.2M | -$595.8M |
| Free cash flow | -$299.9M | -$582.4M | -$608.7M |
| Total assets | $2.9B | $3.0B | $3.9B |
| Total liabilities | $344.2M | $479.9M | $267.6M |
| Shareholders' equity | $2.6B | $2.5B | — |
| Ratios | |||
| Operating margin | -382.0% | -1743.0% | -1627.6% |
| Net margin | -277.5% | -1613.9% | -1574.2% |
| FCF margin | -203.8% | -463.7% | -653.8% |
| Return on assets | -14.0% | -67.9% | -37.4% |
| Return on equity | -15.8% | -81.0% | — |
| Current ratio | 11.97 | 10.66 | 0.95 |
| Revenue growth | 17.2% | 34.9% | — |
Notable holders (13F)
| Investor | Shares | Value |
|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | 55,200 | $2.9M |
| Point72 Asset Management, L.P. | 4,800 | $248,064 |
Why these scores methodology →
Piotroski F-score: 4/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: -2.86 (distress)
- Working capital / assets 0.299
- Retained earnings / assets -3.495
- EBIT / assets -0.192
- Equity / liabilities 7.49
Sector peers
GOOG · MSFT · META · BABA · DIS · HCA · all Services →
Source: SEC EDGAR filings · CIK 0001699031 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.